OBN'S Patron, Media Partner, Corporate Sponsors and Supporters

OBN gratefully acknowledges the moral, financial and in kind support of our Patrons and Corporate Sponsors and Supporters.


Ipsen is a global, mid-sized biopharmaceutical company focused on transformative medicines in Oncology, Rare Disease and Neuroscience.


Provide a vast range of consumables, reagents and equipment to the life sciences industry
A premium business and science park located near Abingdon. Part of the MEPC group
Merck is a long-established major pharmaceutical giant with diverse interests spanning healthcare/medicine development, diagnostics, support of biotech, pharma and biopharma…
A global law firm providing services across many sectors including the life sciences
Precision for Medicine is the first global, precision-medicine, clinical research organization.
Is a firm of European patent and trade mark attorneys, representing a broad range of clients including major domestic and international corporations, SMEs, universities and…
The UK’s leading property provider dedicated to driving the growth of the science and technology sector
Manufactures and supplies laboratory chemicals and laboratory equipment.
Provide bespoke insurance solutions for commercial, business and private clients
Provide a business development database for the life sciences industry
Zyme are OBN’s exclusive Corporate Media Partner
EBD Group specializes in bringing people together, whether face‑to‑face at one of our leading global life science partnering events powered by partneringONE, or virtually through…
Global accounting and financial consultancy
Is a law firm providing legal services to ultra high net worth individuals and growing mid-market companies.


A research based global pharmaceutical company with diverse interests including oncology, neuroscience and diabetes and related complications
Innovate UK
Work with people, companies and partner organisations to find and drive the science and technology innovations that will grow the UK economy and provides invaluable support to the…
Ernst & Young
At EY, our purpose is building a better working world. The insights and services we provide help to create long-term value for clients, people and society, and to build trust in…
Oxford Brookes University Bioinnovation Hub
Opening access to collaboration, innovation, and resources in bioscience.
Mitigo specialise in complete cyber security protection for higher risk industry sectors including financial services, law firms, chambers, accountancy, architects, and more.
Oxford Innovation Limited
Oxford Innovation supports economic growth by providing businesses with Advice, Finance and Space
Discovery Park
Discovery Park is a hub for interdisciplinary innovation, a thriving community for visionary entrepreneurs and leaders and the ideal environment for businesses to start, scale and…
University of Birmingham
Supports academics who want to innovate, take their ideas to market, work with businesses and social enterprises, or enrich their professional lives by doing academic consultancy…
Oxford Bioescalator
Provide flexible lab space near the centre of Oxford to early stage biomedical science companies
Bristol-based deep tech ecosystem, supported and backed by successful entrepreneurs that help scientists and engineers accelerate their ideas and build disruptive businesses.
Air Products
Provides atmospheric and process gases and related equipment to manufacturing markets and is also a supplier of liquefied natural gas process technology and equipment
Provide a business development database for the life sciences industry

Media Partner

Genetic Engineering & Biotechnology News (GEN) is the flagship publication of Mary Ann Liebert, Inc. Celebrating its 40th anniversary in 2021, GEN was the first publication in…
The FreeMind Group specializes in assisting life science organizations secure non-dilutive funding from US federal agencies and private foundations to fund R&D

Investor Supporters

Is a healthcare and life sciences venture capital and growth equity firm managing over $2 billion in capital in seven private healthcare funds in the US and Europe